Publications by authors named "E Lezcano"
International Society of Paediatric Oncology (SIOP) Global Mapping Program: Analysis of healthcare centers in countries of the Latin American Society of Pediatric Oncology (SLAOP).
Pediatr Blood Cancer
November 2024
Background: The International Society of Paediatric Oncology Society Global Mapping Program aims to describe the local pediatric oncology capacities. Here, we report the data from Latin America.
Methods: A 10-question survey was distributed among chairs of pediatric oncology services.
International Society of Paediatric Oncology (SIOP) Global Mapping Programme: Latin American Society of Pediatric Oncology (SLAOP) country-level report.
Pediatr Blood Cancer
June 2024
Article Synopsis
- - Latin American countries are making significant progress in childhood cancer care by implementing the Global Initiative for Childhood Cancer, although there’s limited continental-level data on these efforts.
- - A survey involving 19 out of 20 Latin American countries revealed that nine have national pediatric cancer control programs, and there are resources like tumor registries and fellowship training programs available in many countries.
- - Overall, improvements in child cancer treatment and survivorship are notable in the region, with a correlation between social development and the availability of comprehensive support and resources for pediatric oncology.
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally.
BMC Cancer
June 2022
Background: Gastric Cancer (GC) is the fourth most deadly cancer worldwide. Enhanced understanding of its key epidemiological and molecular drivers is urgently needed to lower the incidence and improve outcomes. Furthermore, tumor biology in European (EU) and Latin American (LATAM) countries is understudied.
View Article and Find Full Text PDFAngiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
Cardiovasc Revasc Med
April 2020
Objectives: This study sought to assess the efficacy of the drug-coated balloon (DCB) ESSENTIAL for the treatment of in-stent restenosis (ISR).
Background: DCBs have proven a valid therapeutic option for the management of ISR in several clinical trials, yet no class effect can be claimed. Accordingly, every new DCB model has to be individually evaluated through clinical studies.